Cargando…
The Ratio of CD86+/CD163+ Macrophages Predicts Postoperative Recurrence in Stage II-III Colorectal Cancer
Tumor-associated macrophages (TAMs) are pivotal for tumor progression and metastasis. We investigated the stromal CD86+TAM/CD163+TAM (CD86/CD163) ratio as a novel prognostic biomarker for stage II-III colorectal cancer (CRC). Two independently clinical cohorts of stage II-III CRC were retrospectivel...
Autores principales: | Xu, Guozeng, Jiang, Lei, Ye, Cheng, Qin, Guizhen, Luo, Zhanxiong, Mo, Yuzhen, Chen, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427131/ https://www.ncbi.nlm.nih.gov/pubmed/34512652 http://dx.doi.org/10.3389/fimmu.2021.724429 |
Ejemplares similares
-
Two tripartite classification systems of CD86(+) and CD206(+) macrophages are significantly associated with tumor recurrence in stage II-III colorectal cancer
por: Xu, Guozeng, et al.
Publicado: (2023) -
High Infiltration of CD203c(+) Mast Cells Reflects Immunosuppression and Hinders Prognostic Benefit in Stage II-III Colorectal Cancer
por: Li, Jing, et al.
Publicado: (2023) -
The number and localization of CD68+ and CD163+ macrophages in different stages of cutaneous melanoma
por: Salmi, Satu, et al.
Publicado: (2019) -
Prognostic significance of CD163+ tumor-associated macrophages in colorectal cancer
por: Xue, Tao, et al.
Publicado: (2021) -
Targeting of CD163(+) Macrophages in Inflammatory and Malignant Diseases
por: Skytthe, Maria K., et al.
Publicado: (2020)